The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on November 9, 2026

Rani Therapeutics Reports Third Quarter 2026 Financial Results; Provides Corporate Update
Life360 Reports Q3 2026 Results
Maze Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights
Surrozen Reports Third Quarter 2026 Financial Results and Provides Business Update
Zentalis Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Updates
Apollomics Reports First-Half 2026 Financial Results
MapLight Therapeutics to Participate in Upcoming Investor Conference
ImageneBio Reports Third Quarter 2026 Financial Results
Trevi Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
The Elmet Group Co. Reports Third Quarter 2026 Results
Castellum Announces $6.0 Million Share Repurchase Program
Oruka Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Harrow Announces Third Quarter 2026 Financial Results
MBX Biosciences Reports Third Quarter 2026 Financial Results and Corporate Highlights
POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN
Annexon Reports Third Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones
IRulya Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.
Black Diamond Therapeutics to Host Webcast Highlighting Updated Silevertinib Phase 2 Data and FDA Feedback Supporting a Clear Phase 3 Path to Potential Accelerated Approval in 1L EGFR-NCM NSCLC
FormFactor Publishes Comprehensive Sustainability Report

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The California STEM Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.